NEWSROOM

Servier and Allogene Therapeutics Announce Data Presentations of UCART19 First-in-Human Trials at 60th American Society of Hematology (ASH) Annual Meeting

12 / 11 / 2018Press release

Servier joins Patient-Focused Medicines Development (PFMD) Collective Platform

25 / 10 / 2018Press release

Servier, in the top 5 companies favoured by students and young graduates

18 / 10 / 2018Press release

Professor Michel Sadelain wins the 2018 Pasteur-Weizmann/Servier Prize for his work on immunoregulation and cancer

16 / 10 / 2018Press release

Servier launches InnoPreP™, Its new preparative chromatography offer under its Contract Development & Manufacturing activity

01 / 10 / 2018Press release

Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

19 / 09 / 2018Press release

Precision medicine: Cap Digital and Medicen Paris-Region team up with Oncodesign, Servier and Intersystems on Hu-PreciMED project

19 / 09 / 2018Press release

GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier

18 / 09 / 2018Press release

Servier finalizes acquisition of Shire’s oncology branch

31 / 08 / 2018Press release

Servier group appoints David K. Lee as CEO of Servier Pharmaceuticals (US)

16 / 07 / 2018Press release

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

27 / 06 / 2018Press release

WeHealth by Servier joins forces with Peter Sheehan Diabetes Care Foundation in the fight against diabetes

12 / 06 / 2018Press release